With that becoming reported, without having human trials there's no way to truly assess how much YK11 can inhibit Myostatin in human beings (if in any way), and when there is a dosage that might equate to exactly the same standard of Myostatin inhibition that a genetic anomaly using a gene mutation has.Together with its capacity to induce expansion